Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2005 Results on Tuesday, February 21, 2006
MONTVALE, N.J., February 14, 2006 -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its fourth quarter and full year 2005 financial results on Tuesday, February 21, 2006, before the U.S. financial markets open. Senior management will provide a Company update and discuss the fourth quarter results during a conference call on Tuesday, February 21, 2006, at 9.00 a.m. EST.
An audio replay of the conference call will be available from 11:00 a.m. EST on Tuesday, February 21, 2006, until Tuesday, February 28, 2006. To access the replay, please dial 888-286-8010 (U.S.) or 617-801-6888 (international) and enter pass code number 25609231. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression, bipolar disorder, vascular dementia, mild cognitive impairment, Parkinson's disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.